BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kinumaki A, Sekizuka T, Hamada H, Kato K, Yamashita A, Kuroda M. Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis. Front Microbiol 2015;6:824. [PMID: 26322033 DOI: 10.3389/fmicb.2015.00824] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Wu X, Zhang H, Chen J, Shang S, Yan J, Chen Y, Tang X, Zhang H. Analysis and comparison of the wolf microbiome under different environmental factors using three different data of Next Generation Sequencing. Sci Rep 2017;7:11332. [PMID: 28900198 DOI: 10.1038/s41598-017-11770-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
2 Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol 2020;16:391-405. [PMID: 32457494 DOI: 10.1038/s41584-020-0426-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
3 Kim JC, Park MJ, Park S, Lee ES. Alteration of the Fecal but Not Salivary Microbiome in Patients with Behçet's Disease According to Disease Activity Shift. Microorganisms 2021;9:1449. [PMID: 34361885 DOI: 10.3390/microorganisms9071449] [Reference Citation Analysis]
4 Rhim JW, Kang HM, Han JW, Lee KY. A Presumed Etiology of Kawasaki Disease Based on Epidemiological Comparison With Infectious or Immune-Mediated Diseases. Front Pediatr 2019;7:202. [PMID: 31165053 DOI: 10.3389/fped.2019.00202] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
5 Miyabe C, Miyabe Y, Miyata R, Ishiguro N. Pathogens in Vasculitis: Is It Really Idiopathic? JMA J 2021;4:216-24. [PMID: 34414315 DOI: 10.31662/jmaj.2021-0021] [Reference Citation Analysis]
6 Tariq S, Clifford AH. An update on the microbiome in vasculitis. Curr Opin Rheumatol 2021;33:15-23. [PMID: 33186243 DOI: 10.1097/BOR.0000000000000758] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Espinoza JL, Ai S, Matsumura I. New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory. Pathogens 2018;7:E73. [PMID: 30200570 DOI: 10.3390/pathogens7030073] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
8 Chen J, Yue Y, Wang L, Deng Z, Yuan Y, Zhao M, Yuan Z, Tan C, Cao Y. Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease. Sci Rep 2020;10:14525. [PMID: 32884012 DOI: 10.1038/s41598-020-71371-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shen J, Ding Y, Yang Z, Zhang X, Zhao M. Effects of changes on gut microbiota in children with acute Kawasaki disease. PeerJ 2020;8:e9698. [PMID: 33005487 DOI: 10.7717/peerj.9698] [Reference Citation Analysis]
10 Coit P, Sawalha AH. The human microbiome in rheumatic autoimmune diseases: A comprehensive review. Clinical Immunology 2016;170:70-9. [DOI: 10.1016/j.clim.2016.07.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
11 Akiyama M, Kaneko Y, Takeuchi T. Does microbiome contribute to HLA-B52-positive Takayasu arteritis? Modern Rheumatology 2020;30:213-7. [DOI: 10.1080/14397595.2019.1584146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Konig MF. The microbiome in autoimmune rheumatic disease. Best Pract Res Clin Rheumatol 2020;34:101473. [PMID: 32044247 DOI: 10.1016/j.berh.2019.101473] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
13 Tomita Y, Fukaya T, Yamaura Y, Tsujiguchi R, Muratani H, Shimaya M. Implications of hepatic dysfunction in Kawasaki disease: Time-related changes in aspartate aminotransferase, alanine aminotransferase, total bilirubin, and C-reactive protein levels. Pediatr Investig 2019;3:19-26. [PMID: 32851284 DOI: 10.1002/ped4.12112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Hamada H, Sekizuka T, Oba K, Katano H, Kinumaki A, Terai M, Mizutani T, Kuroda M. Comprehensive pathogen detection associated with four recurrent episodes of Kawasaki disease in a patient during a single year using next-generation sequencing. JMM Case Rep 2016;3:e005019. [PMID: 28348750 DOI: 10.1099/jmmcr.0.005019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
15 Talotta R, Atzeni F, Ditto MC, Gerardi MC, Sarzi-Puttini P. The Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review. J Immunol Res 2017;2017:6836498. [PMID: 28835902 DOI: 10.1155/2017/6836498] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
16 Lee KY, Hamada H, Arvonen M. Editorial: Infection-Related Immune-Mediated Diseases and Microbiota. Front Pediatr 2020;8:108. [PMID: 32318520 DOI: 10.3389/fped.2020.00108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Takeuchi A, Namba T, Matsumoto N, Tamai K, Nakamura K, Nakamura M, Kageyama M, Kubo T, Tsukahara H, Yorifuji T. Preterm birth and Kawasaki disease: a nationwide Japanese population-based study. Pediatr Res 2021. [PMID: 34625654 DOI: 10.1038/s41390-021-01780-4] [Reference Citation Analysis]
18 Xu H, Wang X, Feng W, Liu Q, Zhou S, Liu Q, Cai L. The gut microbiota and its interactions with cardiovascular disease. Microb Biotechnol 2020;13:637-56. [PMID: 31984651 DOI: 10.1111/1751-7915.13524] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
19 Lee ZM, Chu CL, Chu CH, Chang LS, Kuo HC. Multiple intravenous antibiotics usage is associated with intravenous immunoglobulin resistance in Kawasaki disease. Pediatr Neonatol 2021:S1875-9572(21)00180-7. [PMID: 34716128 DOI: 10.1016/j.pedneo.2021.06.020] [Reference Citation Analysis]
20 Esposito S, Polinori I, Rigante D. The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome. Front Pediatr 2019;7:124. [PMID: 31024869 DOI: 10.3389/fped.2019.00124] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
21 Barbara Z, Ellenwood SP, Loe ED, Choi J, Ryan K, Joseph N. Kawasaki Disease Complicated by Salmonella oranienburg Coinfection. Case Rep Pediatr 2021;2021:5584514. [PMID: 33936828 DOI: 10.1155/2021/5584514] [Reference Citation Analysis]
22 Kaneko K, Akagawa S, Akagawa Y, Kimata T, Tsuji S. Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota. Front Immunol 2020;11:1616. [PMID: 32793240 DOI: 10.3389/fimmu.2020.01616] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Dubé MP, Park SY, Ross H, Love TMT, Morris SR, Lee HY. Daily HIV pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate-emtricitabine reduced Streptococcus and increased Erysipelotrichaceae in rectal microbiota. Sci Rep 2018;8:15212. [PMID: 30315206 DOI: 10.1038/s41598-018-33524-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
24 Rhim JW, Lee YT, Kang HM, Suh JS, Lee KY. Changes in clinical features in Henoch-Schönlein purpura during three decades: an observational study at a single hospital in Korea. Clin Rheumatol 2019;38:2811-8. [PMID: 31209707 DOI: 10.1007/s10067-019-04628-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhao T, Zou S, Chu M, Chen J, Zhong J, Chen Y, Fan J, Qi J, Wang Q. Cell free bacterial DNAs in human plasma provide fingerprints for immune-related diseases. Medicine in Microecology 2020;5:100022. [DOI: 10.1016/j.medmic.2020.100022] [Reference Citation Analysis]
26 Fukazawa M, Fukazawa M, Nanishi E, Nishio H, Ichihara K, Ohga S. Previous antibiotic use and the development of Kawasaki disease: a matched pair case‐control study. Pediatrics International 2020;62:1044-8. [DOI: 10.1111/ped.14255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Porritt RA, Markman JL, Maruyama D, Kocaturk B, Chen S, Lehman TJA, Lee Y, Fishbein MC, Noval Rivas M, Arditi M. Interleukin-1 Beta-Mediated Sex Differences in Kawasaki Disease Vasculitis Development and Response to Treatment. Arterioscler Thromb Vasc Biol 2020;40:802-18. [PMID: 31996019 DOI: 10.1161/ATVBAHA.119.313863] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
28 Fabi M, Corinaldesi E, Pierantoni L, Mazzoni E, Landini C, Bigucci B, Ancora G, Malaigia L, Bodnar T, Di Fazzio G, Lami F, Valletta E, Cicero C, Biasucci G, Iughetti L, Marchetti F, Sogno Valin P, Amarri S, Brusa S, Sprocati M, Maggiore G, Dormi A, Lanzoni P, Donti A, Lanari M. Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease? PLoS One 2018;13:e0202658. [PMID: 30180185 DOI: 10.1371/journal.pone.0202658] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]